Avelumab FDA approval date

The FDA approved Avelumab ((BAVENCIO® injection, for intravenous [IV] use)) on 23 Mar 2017.

FDA approval date
23 Mar 2017

Drug identity checked against registry records

Also recorded as (BAVENCIO® injection, for intravenous [IV] use)

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2017-03-23DayAvelumabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761049", "applicant_as_listed_by_fda": "EMD SERONO INC", "brand_names": ["BAVENCIO"], "active_ingredients": ["AVELUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20170323", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026